Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something.

The first humans are trying out cellular reprogramming for longevity. It looks like it might be working.

Vitamin C and Cell Reprogramming: Making it Easier to Create iPS Cells from Cultured Mouse and Human Cells

Add vitamin C to the culture medium for cells. From this, a connection has emerged between technology that alters cell ...
GEN

Scientists Able to Reprogram Human Embryos Using Human Eggs but Not Animal Eggs

Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
Pulse 2.0

NewLimit Raises $435 Million Series C To Bring Aging Reprogramming Medicine To Human Trials

NewLimit has announced a $435 million Series C led by Founders Fund, alongside new investors Thrive Capital, Greenoaks, and Quiet Capital, and returning investors Kleiner Perkins, Abstract, Nat ...